Insulin (API and Injection) Market Report

Global and Region Insulin (API and Injection) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：210
  • REPORT CODE：GMM885233
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Insulin (API and Injection) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Insulin (API and Injection)market, defines the market attractiveness level of Insulin (API and Injection) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Insulin (API and Injection) industry, describes the types of Insulin (API and Injection) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin (API and Injection) market and the development prospects and opportunities of Insulin (API and Injection) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin (API and Injection) market in Chapter 13.

    By Player:

    • Merck

    • Dongbao

    • United Laboratories

    • Eli Lilly

    • Ganlee

    • Sanofi-Aventis

    • Bioton

    • Novo Nordisk

    By Type:

    • Animal Insulin

    • Human Insulin

    • Insulin Analogue

    By End-User:

    • Diabetes

    • Coronary Heart Disease

    • Perioperation Period

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Insulin (API and Injection) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Insulin (API and Injection) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Insulin (API and Injection) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Insulin (API and Injection) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Insulin (API and Injection) Market Analysis and Outlook to 2022

    • 7.1 Global Insulin (API and Injection) Consumption (2017-2022)

    • 7.2 United States Insulin (API and Injection) Consumption (2017-2022)

    • 7.3 Europe Insulin (API and Injection) Consumption (2017-2022)

    • 7.4 China Insulin (API and Injection) Consumption (2017-2022)

    • 7.5 Japan Insulin (API and Injection) Consumption (2017-2022)

    • 7.6 India Insulin (API and Injection) Consumption (2017-2022)

    • 7.7 South Korea Insulin (API and Injection) Consumption (2017-2022)

    8 Region and Country-wise Insulin (API and Injection) Market Analysis and Outlook to 2028

    • 8.1 Global Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.2 United States Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.3 Europe Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.4 China Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.5 Japan Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.6 India Insulin (API and Injection) Consumption Forecast (2022-2028)

    • 8.7 South Korea Insulin (API and Injection) Consumption Forecast (2022-2028)

    9 Global Insulin (API and Injection) Market Outlook by Types and Applications to 2022

    • 9.1 Global Insulin (API and Injection) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Animal Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Human Insulin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Insulin Analogue Consumption and Growth Rate (2017-2022)

    • 9.2 Global Insulin (API and Injection) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Perioperation Period Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Insulin (API and Injection) Market Outlook by Types and Applications to 2028

    • 10.1 Global Insulin (API and Injection) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Animal Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Human Insulin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Insulin Analogue Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Insulin (API and Injection) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Perioperation Period Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Insulin (API and Injection) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Insulin (API and Injection) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Insulin (API and Injection) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Insulin (API and Injection) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Insulin (API and Injection) Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Insulin (API and Injection) Product and Service

    • 14.2 Dongbao

      • 14.2.1 Dongbao Company Details

      • 14.2.2 Dongbao Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Dongbao Insulin (API and Injection) Product and Service

    • 14.3 United Laboratories

      • 14.3.1 United Laboratories Company Details

      • 14.3.2 United Laboratories Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 United Laboratories Insulin (API and Injection) Product and Service

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Details

      • 14.4.2 Eli Lilly Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly Insulin (API and Injection) Product and Service

    • 14.5 Ganlee

      • 14.5.1 Ganlee Company Details

      • 14.5.2 Ganlee Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ganlee Insulin (API and Injection) Product and Service

    • 14.6 Sanofi-Aventis

      • 14.6.1 Sanofi-Aventis Company Details

      • 14.6.2 Sanofi-Aventis Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sanofi-Aventis Insulin (API and Injection) Product and Service

    • 14.7 Bioton

      • 14.7.1 Bioton Company Details

      • 14.7.2 Bioton Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bioton Insulin (API and Injection) Product and Service

    • 14.8 Novo Nordisk

      • 14.8.1 Novo Nordisk Company Details

      • 14.8.2 Novo Nordisk Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novo Nordisk Insulin (API and Injection) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Insulin (API and Injection)

    • Figure Insulin (API and Injection) Picture

    • Table Global Insulin (API and Injection) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin (API and Injection) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Insulin (API and Injection) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Insulin (API and Injection) Consumption by Country (2017-2022)

    • Figure United States Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Table Europe Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Figure China Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Figure Japan Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Figure India Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Insulin (API and Injection) Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin (API and Injection) Consumption Forecast by Country (2022-2028)

    • Figure United States Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Insulin (API and Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Animal Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Human Insulin Consumption and Growth Rate (2017-2022)

    • Figure Global Insulin Analogue Consumption and Growth Rate (2017-2022)

    • Figure Global Diabetes Consumption and Growth Rate (2017-2022)

    • Figure Global Coronary Heart Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Perioperation Period Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Animal Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Human Insulin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Insulin Analogue Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coronary Heart Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Perioperation Period Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Insulin (API and Injection) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Insulin (API and Injection) Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Insulin (API and Injection) Product and Service

    • Table Dongbao (Foundation Year, Company Profile and etc.)

    • Table Dongbao Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongbao Insulin (API and Injection) Product and Service

    • Table United Laboratories (Foundation Year, Company Profile and etc.)

    • Table United Laboratories Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table United Laboratories Insulin (API and Injection) Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Insulin (API and Injection) Product and Service

    • Table Ganlee (Foundation Year, Company Profile and etc.)

    • Table Ganlee Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ganlee Insulin (API and Injection) Product and Service

    • Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)

    • Table Sanofi-Aventis Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Insulin (API and Injection) Product and Service

    • Table Bioton (Foundation Year, Company Profile and etc.)

    • Table Bioton Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioton Insulin (API and Injection) Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Insulin (API and Injection) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Insulin (API and Injection) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US